GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (OTCPK:LTPCF) » Definitions » Cyclically Adjusted Book per Share

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Cyclically Adjusted Book per Share : $0.00 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Lotus Pharmaceutical Co Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lotus Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2024 was $2.270. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lotus Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 16.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lotus Pharmaceutical Co was 16.80% per year. The lowest was 13.00% per year. And the median was 14.90% per year.

As of today (2024-06-11), Lotus Pharmaceutical Co's current stock price is $0.00. Lotus Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.00. Lotus Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lotus Pharmaceutical Co was 9.02. The lowest was 1.96. And the median was 4.01.


Lotus Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lotus Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lotus Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lotus Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lotus Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Lotus Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lotus Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.27/131.7762*131.7762
=2.270

Current CPI (Mar. 2024) = 131.7762.

Lotus Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.589 100.560 0.772
201409 0.920 100.428 1.207
201412 1.056 99.070 1.405
201503 1.039 99.621 1.374
201506 1.061 100.684 1.389
201509 1.004 100.392 1.318
201512 0.998 99.792 1.318
201603 1.014 100.470 1.330
201606 1.019 101.688 1.321
201609 1.048 101.861 1.356
201612 0.974 101.863 1.260
201703 1.023 102.862 1.311
201706 1.001 103.349 1.276
201709 1.014 104.136 1.283
201712 1.014 104.011 1.285
201803 1.038 105.290 1.299
201806 0.994 106.317 1.232
201809 0.989 106.507 1.224
201812 0.984 105.998 1.223
201903 1.013 107.251 1.245
201906 1.027 108.070 1.252
201909 1.033 108.329 1.257
201912 1.069 108.420 1.299
202003 1.058 108.902 1.280
202006 1.117 108.767 1.353
202009 1.186 109.815 1.423
202012 1.300 109.897 1.559
202103 1.350 111.754 1.592
202106 1.612 114.631 1.853
202109 1.640 115.734 1.867
202112 1.673 117.630 1.874
202203 1.706 121.301 1.853
202206 1.610 125.017 1.697
202209 1.802 125.227 1.896
202212 1.897 125.222 1.996
202303 1.934 127.348 2.001
202306 2.097 128.729 2.147
202309 2.197 129.860 2.229
202312 2.326 129.419 2.368
202403 2.270 131.776 2.270

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lotus Pharmaceutical Co  (OTCPK:LTPCF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lotus Pharmaceutical Co was 9.02. The lowest was 1.96. And the median was 4.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lotus Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lotus Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. It is engaged in generic drug business segment, which engages mainly in the research and development, manufacturing and sales of generic pharmaceutical products. It has its geographic presence in United States, South Korea and Others.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Headlines

From GuruFocus